InvestorsHub Logo
Followers 3
Posts 596
Boards Moderated 0
Alias Born 10/19/2016

Re: None

Tuesday, 12/13/2022 10:44:48 AM

Tuesday, December 13, 2022 10:44:48 AM

Post# of 13431
A DOUBLE WHAMMY for MRNA. New investigational drug application approved for mrna drug targeting cystic fibrosis. This could be huge for the future of the company (and for the thousands of patients with this tragic disease). Thank you, Axelvento for keeping us aware of the pipeline of new therapies that Moderna is working on.

The personalized cancer vaccine has phase 2a data for melanoma used along with Merck’s drug, Keytruda. The stock is only up 25% today! The future is bright!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News